Year: 2023

AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for the Treatment of Advanced Recurrent Ovarian Cancer

Data presented at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting Longitudinal comparison of biomarkers in tumor microenvironment...

Healthcare Triangle to Host Sessions on Digital Transformation and Ransomware Preparedness for Healthcare Systems at CHIME23 Fall Forum

PLEASANTON, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc (Nasdaq: HCTI) (“HCTI” or the "Company"), a leader in digital...

error: Content is protected !!